Leah Caroline Thomas Byrne

Pittsburgh, PA, United States of America

Leah Caroline Thomas Byrne

USPTO Granted Patents = 12 

Average Co-Inventor Count = 6.3

ph-index = 6

Forward Citations = 236(Granted Patents)


Location History:

  • Paris, FR (2018)
  • Berkeley, CA (US) (2015 - 2022)
  • San Francisco, CA (US) (2023)

Company Filing History:


Years Active: 2015-2023

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Journey of Leah Caroline Thomas Byrne

Introduction

Leah Caroline Thomas Byrne, an accomplished inventor based in Pittsburgh, PA, has made significant contributions to the field of genetic engineering and ocular health. With a remarkable portfolio of 12 patents, Leah’s work focuses on advancing therapies that leverage adeno-associated viruses for innovative medical applications.

Latest Patents

Among her latest inventions are notable patents related to adeno-associated virus (AAV) virions with variant capsids. These patents detail how these AAV virions, which have modified capsid proteins, demonstrate greater infectivity of retinal cells in comparison to wild-type AAV. Furthermore, her disclosures include methods for effectively delivering gene products to retinal cells in individuals, along with novel approaches for treating ocular diseases.

Career Highlights

Leah's career has been marked by her influential roles at prestigious institutions, namely the University of California and the University of Pennsylvania. Her experiences in these environments have enabled her to innovate and collaborate on research that addresses critical health challenges.

Collaborations

Throughout her career, Leah has collaborated with esteemed colleagues, including John G. Flannery and David V. Schaffer. These collaborations have fostered an environment of creativity and innovation, pushing the boundaries of scientific understanding in gene therapy and ocular treatments.

Conclusion

Leah Caroline Thomas Byrne stands out as a trailblazer in the realm of genetic engineering, especially concerning ocular health. With her extensive expertise and innovative patents, she continues to pave the way for future advancements that hold promise for treating retinal diseases and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…